HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya
Year: 2018
Type: article
Study design: Observational Study
Abstract: BACKGROUND: HIV-1 molecular epidemiology amongst men who have sex with men (MSM) in sub-Saharan Africa remains not well characterized. We aimed to determine HIV-1 subtype distribution, transmission clusters and transmitted drug resistance (TDR) in acute and early infected MSM from Coastal Kenya. METHODS: Analysis of HIV-1 partial pol sequences from MSM recruited 2005-2017 and sampled within six months of the estimated date of infection. Volunteers were classified as men who have sex with men exclusively (MSME) or with both men and women (MSMW). HIV-1 subtype and transmission clusters were determined by maximum-likelihood phylogenetics. TDR mutations were determined using the Stanford HIV drug resistance database. RESULTS: Of the 97 volunteers, majority (69%) were MSMW; 74%, 16%, 9% and 1% had HIV-1 subtypes A1, D, C or G, respectively. Overall, 65% formed transmission clusters, with substantial mixing between MSME and MSMW. Majority of volunteer sequences were either not linked to any reference sequence (56%) or clustered exclusively with sequences of Kenyan origin (19%). Eight (8% [95% CI: 4-16]) had at least one TDR mutation against nucleoside (n = 2 [2%]) and/or non-nucleoside (n = 7 [7%]) reverse transcriptase inhibitors. The most prevalent TDR mutation was K103N (n = 5), with sequences forming transmission clusters of two and three taxa each. There were no significant differences in HIV-1 subtype distribution and TDR between MSME and MSMW. CONCLUSIONS: This HIV-1 MSM epidemic was predominantly sub-subtype A1, of Kenyan origin, with many transmission clusters and having intermediate level of TDR. Targeted HIV-1 prevention, early identification and care interventions are warranted to break the transmission cycle amongst MSM from Coastal Kenya.
Source: PLoS ONE
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: United States Agency for International Development, International AIDS Vaccine Initiative, Wellcome Trust, Government of the United Kingdom, Svenska Sällskapet för Medicinsk Forskning, Vetenskapsrådet, New Partnership for Africa's Development, African Academy of Sciences, National Institutes of Health, Alliance for Accelerating Excellence in Science in Africa
Awards: The discriminatory ability of pre-treatment HIV-1 low frequency drug resistance variants to predict antiretroviral treatment outcomes, Characterization of hyperacute HIV infection in adults and infants to increase the understanding of HIV pathogenesis and opportunities for prevention, G3000957577, G4137015471, G4156438909, Sub-Saharan African Network for TB/HIV research Excellence (SANTHE), G5901762629, G6590892262, G6868616705, G704771751, G8183321107, G8445079486, G8488937646, Sub-Saharan African Network for TB/HIV research Excellence (SANTHE)
OpenAlex ID: W2904362408
